» Articles » PMID: 38541306

Knowledge and Awareness of HPV, the HPV Vaccine and Cancer-Related HPV Types Among Indigenous Australians

Overview
Publisher MDPI
Date 2024 Mar 28
PMID 38541306
Authors
Affiliations
Soon will be listed here.
Abstract

Human Papilloma Virus (HPV) infection is a common, preventable, sexually transmitted disease with oncogenic potential and increasing incidence. This study aimed to gain an understanding of the knowledge and awareness of HPV, the HPV vaccine, and HPV-related cancers, and to evaluate the relationship between participant factors and HPV knowledge, vaccination uptake, and high-risk HPV (16/18) infection, among Indigenous Australians. Data from the 12-month follow-up of a longitudinal cohort study were utilized, involving 763 Indigenous Australian adults in South Australia. The data analysis found that the mean 7-item HPV knowledge tool (HPV-KT) score was 2.3 (95% CI: 2.1-2.4), HPV vaccination prevalence was 27.0% (95% CI: 23.6-30.5) and oral HPV 16/18 infection was 4.7% (95% CI: 3.2-6.2). Multivariable log-Poisson regression models showed ratios of approximately 1.5 times higher HPV-KT scores in females, previous recreational drug users, those who had self-rated as having excellent, very good or good general health and who had heard of HPV; and participants who were not HPV vaccinated had 0.8 times (MR = 0.8, 95% CI: 0.7-0.9) lower HPV-KT scores than their counterparts. The findings suggest that culturally safe education strategies are a necessary investment to improve vaccination coverage among Indigenous Australians and to reduce the impact of HPV and related cancers.

References
1.
Brotherton J, Winch K, Chappell G, Banks C, Meijer D, Ennis S . HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015. Med J Aust. 2019; 211(1):31-36. DOI: 10.5694/mja2.50221. View

2.
Jamieson L, Antonsson A, Garvey G, Ju X, Smith M, Logan R . Prevalence of Oral Human Papillomavirus Infection Among Australian Indigenous Adults. JAMA Netw Open. 2020; 3(6):e204951. PMC: 7280951. DOI: 10.1001/jamanetworkopen.2020.4951. View

3.
Lechner M, Breeze C, OMahony J, Masterson L . Early detection of HPV-associated oropharyngeal cancer. Lancet. 2019; 393(10186):2123. DOI: 10.1016/S0140-6736(19)30227-2. View

4.
Gopalani S, Janitz A, Burkhart M, Campbell J, Chen S, Martinez S . HPV vaccination coverage and factors among American Indians in Cherokee Nation. Cancer Causes Control. 2022; 34(3):267-275. PMC: 9768789. DOI: 10.1007/s10552-022-01662-y. View

5.
Wood Z, Bain C, Smith D, Whiteman D, Antonsson A . Oral human papillomavirus infection incidence and clearance: a systematic review of the literature. J Gen Virol. 2017; 98(4):519-526. DOI: 10.1099/jgv.0.000727. View